ipamorelin pill – SQRL PEPTIDE LABS Ipamorelin: The Selective GH Secretagogue

Although testosterone (T) administration can increase insulin-like growth factor-I (IGF-I) when administered to hypogonadal men, no studies have examined whether this occurs in normal men

A solution of 3-(4-(pyridin-2-yldiazenyl)phenoxy)propan-1-ol (26 mg, 0.1 mmol) in methanol (10 mL) was dropwise added

The two pathways converge on GH release but through different intracellular cascades, which is why combining a GHS-R1a agonist (like ipamorelin) with a GHRH analog (like CJC-1295) produces a synergistic rather than merely additive GH response

As part of the broader sermorelin vs CJC-1295 vs ipamorelin comparison, CJC-1295 without DAC has a ~30-minute half-life and produces pulsatile GH release similar to sermorelin but with better enzymatic resistance

Filling, capping, and labeling are performed in a controlled environment, and each vial is laser-coded with a lot number that links directly to the chromatograms produced during release testing